A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|180|4|550-562

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.4, 2018-02, pp. : 550-562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PAX5 alterations in genetically unclassified childhood Precursor B‐cell acute lymphoblastic leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 263-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

PAX5 alterations in genetically unclassified childhood Precursor B‐cell acute lymphoblastic leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 263-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+BL and pre‐B‐ALL

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 763-775

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibody‐based therapies in B‐cell lineage acute lymphoblastic leukaemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 99-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 813-817

John Wiley & Sons Inc

Access to resources Recommend Favorite